- Home
- Publications
- Publication Search
- Publication Details
Title
Lipoxin-mediated signaling: ALX/FPR2 interaction and beyond
Authors
Keywords
-
Journal
PHARMACOLOGICAL RESEARCH
Volume 197, Issue -, Pages 106982
Publisher
Elsevier BV
Online
2023-11-03
DOI
10.1016/j.phrs.2023.106982
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lipoxin Mimetics and the Resolution of Inflammation
- (2023) Catherine Godson et al. Annual Review of Pharmacology and Toxicology
- Electrical Stimulation of the Auricular Branch Vagus Nerve Using Random and Alternating Frequencies Triggers a Rapid Onset and Pronounced Antihyperalgesia via Peripheral Annexin A1-Formyl Peptide Receptor 2/ALX Pathway in a Mouse Model of Persistent Inflammatory Pain
- (2023) Daiana C. Salm et al. MOLECULAR NEUROBIOLOGY
- Intra-Airway Treatment with Synthetic Lipoxin A4 and Resolvin E2 Mitigates Neonatal Asthma Triggered by Maternal Exposure to Environmental Particles
- (2023) Mohankumar Ramar et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Serum lipid mediator profiles in COVID-19 patients and lung disease severity: a pilot study
- (2023) Pilar Irún et al. Scientific Reports
- Lipoxin A4 Receptor Stimulation Attenuates Neuroinflammation in a Mouse Model of Intracerebral Hemorrhage
- (2022) Risa Futokoro et al. Brain Sciences
- Combination of resolvin E1 and lipoxin A4 promotes the resolution of pulpitis by inhibiting NF‐κB activation through upregulating sirtuin 7 in dental pulp fibroblasts
- (2022) Xiaochen Liu et al. CELL PROLIFERATION
- Lipoxin A4 regulates M1/M2 macrophage polarization via FPR2–IRF pathway
- (2022) Jixiang Yuan et al. INFLAMMOPHARMACOLOGY
- Specialized Proresolving Mediators Protect Against Experimental Autoimmune Myocarditis by Modulating Ca2+ Handling and NRF2 Activation
- (2022) Almudena Val-Blasco et al. JACC-Basic to Translational Science
- Lipid emulsion rich in n–3 polyunsaturated fatty acids elicits a pro-resolution lipid mediator profile in mouse tissues and in human immune cells
- (2022) Nazek Noureddine et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Formylpeptide receptor 2: Nomenclature, structure, signalling and translational perspectives: IUPHAR review 35
- (2022) Cheng Xue Qin et al. BRITISH JOURNAL OF PHARMACOLOGY
- Interferon-β regulates proresolving lipids to promote the resolution of acute airway inflammation
- (2022) Meriem Sekheri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lipoxin A4 depresses inflammation and promotes autophagy via AhR/mTOR/AKT pathway to suppress endometriosis
- (2022) Zhi‐Xiong Huang et al. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- Protectins: Their biosynthesis, metabolism and structure-functions
- (2022) Trond Vidar Hansen et al. BIOCHEMICAL PHARMACOLOGY
- Annexin A1 (Ac2-26)-dependent Fpr2 receptor alleviates sepsis-induced acute kidney injury by inhibiting inflammation and apoptosis in vivo and in vitro
- (2022) Yanlei Zheng et al. INFLAMMATION RESEARCH
- Recent advances in the design and development of formyl peptide receptor 2 (FPR2/ALX) agonists as pro-resolving agents with diverse therapeutic potential
- (2021) Monika Maciuszek et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Lipoxin A4 regulates microglial M1/M2 polarization after cerebral ischemia-reperfusion injury via the Notch signaling pathway
- (2021) Qian-Qian Li et al. EXPERIMENTAL NEUROLOGY
- Resolution of inflammation: An organizing principle in biology and medicine
- (2021) Dipak Panigrahy et al. PHARMACOLOGY & THERAPEUTICS
- Resolution-Based Therapies: The Potential of Lipoxins to Treat Human Diseases
- (2021) Rafael I. Jaén et al. Frontiers in Immunology
- Eicosanoid receptors as therapeutic targets for asthma
- (2021) William S. Powell CLINICAL SCIENCE
- Lipoxin A4 activates ALX/FPR2 to attenuate inflammation in Aspergillus fumigatus keratitis
- (2021) Xiaojia Zhu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Time-Dependent Protective and Pro-Resolving Effects of FPR2 Agonists on Lipopolysaccharide-Exposed Microglia Cells Involve Inhibition of NF-κB and MAPKs Pathways
- (2021) Kinga Tylek et al. Cells
- Specialized Proresolving Lipid Meditators Agonistic to Formyl Peptide Receptor Type 2 Attenuate Ischemia-reperfusion Injury in Rat Lung
- (2021) Hiromi Oda et al. TRANSPLANTATION
- Structure of formylpeptide receptor 2-Gi complex reveals insights into ligand recognition and signaling
- (2020) Youwen Zhuang et al. Nature Communications
- Ozone-Induced Aryl Hydrocarbon Receptor Activation Controls Lung Inflammation via Interleukin-22 Modulation
- (2020) Chloé Michaudel et al. Frontiers in Immunology
- Formyl peptide receptor type 2 agonists to kick‐start resolution pharmacology
- (2020) Mauro Perretti et al. BRITISH JOURNAL OF PHARMACOLOGY
- Specialized pro-resolving mediator network: an update on production and actions
- (2020) Nan Chiang et al. Essays in Biochemistry
- Dysregulated metabolism of polyunsaturated fatty acids in eosinophilic allergic diseases
- (2020) Jun Miyata et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- LXA4-FPR2 signaling regulates radiation-induced pulmonary fibrosis via crosstalk with TGF-β/Smad signaling
- (2020) Hyunjung Kim et al. Cell Death & Disease
- Cutting Edge: Severe SARS-CoV-2 Infection in Humans Is Defined by a Shift in the Serum Lipidome, Resulting in Dysregulation of Eicosanoid Immune Mediators
- (2020) Benjamin Schwarz et al. JOURNAL OF IMMUNOLOGY
- The relationship between specialized pro-resolving lipid mediators, morbid obesity and weight loss after bariatric surgery
- (2020) Fabian Schulte et al. Scientific Reports
- Mesenchymal Stem Cells Reverse Diabetic Nephropathy Disease via Lipoxin A4 by Targeting Transforming Growth Factor β (TGF-β)/smad Pathway and Pro-Inflammatory Cytokines
- (2019) Yihua Bai et al. MEDICAL SCIENCE MONITOR
- The contribution of formyl peptide receptor dysfunction to the course of neuroinflammation: A potential role in the brain pathology.
- (2019) Ewa Trojan et al. Current Neuropharmacology
- Phosphoproteomic analysis sheds light on intracellular signaling cascades triggered by Formyl-Peptide Receptor 2
- (2019) Fabio Cattaneo et al. Scientific Reports
- Lipoxin A4 inhibited the activation of hepatic stellate cells -T6 cells by modulating profibrotic cytokines and NF-κB signaling pathway
- (2019) Ting Zhang et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators
- (2018) Charles N. Serhan et al. JOURNAL OF CLINICAL INVESTIGATION
- Lipoxins Regulate the Early Growth Response–1 Network and Reverse Diabetic Kidney Disease
- (2018) Eoin P. Brennan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Lipoxin A4 Attenuates the Inflammatory Response in Stem Cells of the Apical Papilla via ALX/FPR2
- (2018) A. Gaudin et al. Scientific Reports
- Lipoxin and Resolvin Receptors Transducing the Resolution of Inflammation in Cardiovascular Disease
- (2018) John Pirault et al. Frontiers in Pharmacology
- Annexin A1 and specialized proresolving lipid mediators: promoting resolution as a therapeutic strategy in human inflammatory diseases
- (2017) Luiza Oliveira Perucci et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Formyl peptide receptor 1 suppresses gastric cancer angiogenesis and growth by exploiting inflammation resolution pathways
- (2017) Nella Prevete et al. OncoImmunology
- Formyl-Peptide Receptor 2/3/Lipoxin A4Receptor Regulates Neutrophil-Platelet Aggregation and Attenuates Cerebral InflammationCLINICAL PERSPECTIVE
- (2016) Shantel A. Vital et al. CIRCULATION
- Airway lipoxin A 4 /formyl peptide receptor 2–lipoxin receptor levels in pediatric patients with severe asthma
- (2016) Rosalia Gagliardo et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Lipoxin A4 inhibits microglial activation and reduces neuroinflammation and neuropathic pain after spinal cord hemisection
- (2016) Alessandra Cadete Martini et al. Journal of Neuroinflammation
- Lipoxin A4 activates ALX/FPR2 receptor to regulate conjunctival goblet cell secretion
- (2016) R R Hodges et al. Mucosal Immunology
- Proresolving lipid mediators resolvin D1, resolvin D2, and maresin 1 are critical in modulating T cell responses
- (2016) Valerio Chiurchiù et al. Science Translational Medicine
- Lipoxin A4 Reduces Inflammation Through Formyl Peptide Receptor 2/p38 MAPK Signaling Pathway in Subarachnoid Hemorrhage Rats
- (2016) Zongduo Guo et al. STROKE
- Lipoxin A4 Counter-regulates Histamine-stimulated Glycoconjugate Secretion in Conjunctival Goblet Cells
- (2016) Robin R. Hodges et al. Scientific Reports
- Lipoxin A4Attenuates Constitutive and TGF-β1–Dependent Profibrotic Activity in Human Lung Myofibroblasts
- (2015) Katy M. Roach et al. JOURNAL OF IMMUNOLOGY
- Human Mesenchymal Stem (Stromal) Cells Promote the Resolution of Acute Lung Injury in Part through Lipoxin A4
- (2015) Xiaohui Fang et al. JOURNAL OF IMMUNOLOGY
- The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution
- (2015) Charles N. Serhan et al. SEMINARS IN IMMUNOLOGY
- Human Periodontal Stem Cells Release Specialized Proresolving Mediators and Carry Immunomodulatory and Prohealing Properties Regulated by Lipoxins
- (2015) Eleonora Cianci et al. Stem Cells Translational Medicine
- Aspirin-triggered 15-epi-lipoxin A4 regulates neutrophil-platelet aggregation and attenuates acute lung injury in mice
- (2014) G. Ortiz-Munoz et al. BLOOD
- Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7
- (2014) Magnus Bäck et al. BRITISH JOURNAL OF PHARMACOLOGY
- The role of the FPR2/ALX receptor in atherosclerosis development and plaque stability
- (2014) Marcelo H. Petri et al. CARDIOVASCULAR RESEARCH
- Targeting cellular drivers and counter-regulators of hyperglycaemia- and transforming growth factor-β1-associated profibrotic responses in diabetic kidney disease
- (2014) Neil G. Docherty et al. EXPERIMENTAL PHYSIOLOGY
- Lipoxin A4 Suppresses Lipopolysaccharide-Induced Hela Cell Proliferation and Migration via NF-κB Pathway
- (2014) Hua Hao et al. INFLAMMATION
- A vasculo-protective circuit centered on lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 operative in murine microcirculation
- (2013) V. Brancaleone et al. BLOOD
- Resolution phase lipid mediators of inflammation: agonists of resolution
- (2013) Charles N. Serhan et al. CURRENT OPINION IN PHARMACOLOGY
- Distinct Signaling Cascades Elicited by Different Formyl Peptide Receptor 2 (FPR2) Agonists
- (2013) Fabio Cattaneo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Ligand-specific conformational change of the G-protein-coupled receptor ALX/FPR2 determines proresolving functional responses
- (2013) S. N. Cooray et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting Neutrophil Apoptosis for Enhancing the Resolution of Inflammation
- (2013) Driss El Kebir et al. Cells
- Annexin A1, formyl peptide receptor, and NOX1 orchestrate epithelial repair
- (2012) Giovanna Leoni et al. JOURNAL OF CLINICAL INVESTIGATION
- Lipoxin A4 Stimulates Calcium-Activated Chloride Currents and Increases Airway Surface Liquid Height in Normal and Cystic Fibrosis Airway Epithelia
- (2012) Valia Verrière et al. PLoS One
- Transcriptional regulation of the human FPR2/ALX gene: evidence of a heritable genetic variant that impairs promoter activity
- (2011) Felice Simiele et al. FASEB JOURNAL
- Aspirin-triggered lipoxin A4 attenuates LPS-induced pro-inflammatory responses by inhibiting activation of NF-κB and MAPKs in BV-2 microglial cells
- (2011) Yan-Ping Wang et al. Journal of Neuroinflammation
- An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
- (2011) Christiane A. Opitz et al. NATURE
- Pleiotropic regulation of macrophage polarization and tumorigenesis by formyl peptide receptor-2
- (2011) Y Li et al. ONCOGENE
- Lipoxin A4 impairment of apoptotic signaling in macrophages: implication of the PI3K/Akt and the ERK/Nrf-2 defense pathways
- (2010) P Prieto et al. CELL DEATH AND DIFFERENTIATION
- Novel Lipid Mediators Promote Resolution of Acute Inflammation
- (2010) Matthew Spite et al. CIRCULATION RESEARCH
- Transcriptional Factor Aryl Hydrocarbon Receptor (Ahr) Controls Cardiovascular and Respiratory Functions by Regulating the Expression of theVav3Proto-oncogene
- (2010) Vincent Sauzeau et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Anti-Inflammatory Role of the Murine Formyl-Peptide Receptor 2: Ligand-Specific Effects on Leukocyte Responses and Experimental Inflammation
- (2010) Neil Dufton et al. JOURNAL OF IMMUNOLOGY
- Resolvin D1 binds human phagocytes with evidence for proresolving receptors
- (2010) S. Krishnamoorthy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lipoxin A4 inhibits IL-1β-induced IL-8 and ICAM-1 expression in 1321N1 human astrocytoma cells
- (2009) Yann Decker et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family
- (2009) R. D. Ye et al. PHARMACOLOGICAL REVIEWS
- Airway Lipoxin A4Generation and Lipoxin A4Receptor Expression Are Decreased in Severe Asthma
- (2008) Anna Planagumà et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now